We have also shown that IL-27 plays a role in modulating chemosensitivity to cytarabine and daunorubicin, suggesting that IL-27 may be an important determinant of drug resistance in AML and erythroleukemic cells. The gene discussed is IL27; the disease is acute myeloid leukemia.